Cue Biopharma prices 12M stock offering
| CUE Stock | USD 1.49 0.07 4.93% |
About 55% of Cue Biopharma's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Cue Biopharma suggests that some traders are interested. The current market sentiment, together with Cue Biopharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Cue Biopharma stock news signals to limit their universe of possible portfolio assets.
Cue |
Cue Biopharma prices public offering of 11.56M shares and warrant, expecting gross proceeds of 12M.
Read at seekingalpha.com
 |
Cue Biopharma Fundamental Analysis
We analyze Cue Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cue Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cue Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Cue Biopharma is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Cue Biopharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cue Biopharma stock to make a market-neutral strategy. Peer analysis of Cue Biopharma could also be used in its relative valuation, which is a method of valuing Cue Biopharma by comparing valuation metrics with similar companies.
Peers
Cue Biopharma Related Equities
| DRMA | Dermata Therapeutics | 5.31 | ||||
| PYPD | PolyPid | 4.24 | ||||
| LTRN | Lantern Pharma | 3.73 | ||||
| XFOR | X4 Pharmaceuticals | 2.00 | ||||
| TCRX | Tscan Therapeutics | 0.49 | ||||
| DAWN | Day One | 0.41 | ||||
| ANIX | Anixa Biosciences | 0.32 | ||||
| TERN | Terns Pharmaceuticals | 0.49 | ||||
| HOOK | Hookipa Pharma | 0.53 | ||||
| FENC | Fennec Pharmaceuticals | 0.89 | ||||
| INMB | INmune Bio | 1.29 | ||||
| CGTX | Cognition Therapeutics | 3.28 | ||||
| INAB | In8bio | 9.38 |
Complementary Tools for Cue Stock analysis
When running Cue Biopharma's price analysis, check to measure Cue Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cue Biopharma is operating at the current time. Most of Cue Biopharma's value examination focuses on studying past and present price action to predict the probability of Cue Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cue Biopharma's price. Additionally, you may evaluate how the addition of Cue Biopharma to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |